4A41.20ICD-11 MMS 2026-01
Inflammatory inclusion body myositis
Description
Inclusion body myositis (IBM) is the most common idiopathic inflammatory myopathy after age 50. It typically presents with chronic insidious proximal leg and/or distal arm asymmetric muscle weakness leading to recurrent falls and loss of dexterity. Creatine kinase is up to 15 times elevated in IBM and needle electromyography mostly shows a chronic irritative myopathy. Muscle histopathology demonstrates endomysial inflammatory exudates surrounding and invading non-necrotic muscle fibres often times accompanied by rimmed vacuoles and protein deposits. Despite inflammatory muscle pathology, it is likely that IBM has a prominent degenerative component as supported by refractoriness to immunosuppressive therapy.
Index terms
- Inflammatory inclusion body myositis
- Inflammatory IBM - [inflammatory inclusion body myositis]
- Sporadic inclusion body myositis
Show allHide
- Hereditary inclusion body myositis
- Familial inclusion body myositis
- UPD-GlcNac epimerase/kinase deficiency
Excludes
- http://id.who.int/icd/entity/1425591047 – Myasthenia gravis or certain specified neuromuscular junction disorders
Exclusions from above levels
Sibling codes
Foundation entity
Inflammatory inclusion body myositis – http://id.who.int/icd/entity/797555186
Part of: 4A41.2: Inclusion body myopathy › 4A41: Idiopathic inflammatory myopathy › 04: Diseases of the immune system